Skip to content

Evaluation of fluorescence imaging with indocyanine green during hepatectomy

Evaluation of fluorescence imaging with indocyanine green during hepatectomy - Evaluation of fluorescence imaging with indocyanine green during hepatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031054
Enrollment
100
Registered
2018-02-08
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic tumors

Interventions

1.Injection of indocyanine green before the operation (0.5mg/kg) 2.Assess the availability of detection of anatomical border by indocyanine green

Sponsors

Kobe University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with 20 years or older with written informed consent 2. Hepatic tumors proven pathologically 3. Patients who are eligible for hepatectomy

Exclusion criteria

Exclusion criteria: 1. Patients who have allergy with indocyanine grenn 2. When doctors judge as inappropriate

Design outcomes

Primary

MeasureTime frame
Availability of the detection of liver segment with indocyanine green during anatomical liver resection

Countries

Japan

Contacts

Public ContactMasahiro Kido

Kobe universtiy Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery

komasho8@gmail.com+81783826302

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026